A Monoclonal Antibody Targeting a Large Surface of the Receptor Binding Motif Shows Pan-Neutralizing SARS-CoV-2 Activity

Researchers reported the characterization of 17T2, a SARS-CoV-2 pan-neutralizing human monoclonal antibody isolated from a COVID-19 convalescent individual infected during the first pandemic wave.